Article Image
News Link • Science, Medicine and Technology

Fusion molecule found to cure rheumatoid arthritis in mice

But researchers from ETH Zurich, Switzerland have developed a new therapy that has shown to fully cure the condition in mice, leaving the team hopeful of commencing human trials as early as 2015.

The researchers developed a new type of molecule where an antibody is fused with the body's own immune messenger interleukin (IL-4). When injected, the antibody is drawn to a certain type of protein that only exists in inflamed tissue, taking the IL-4 component along for the ride. Previous studies have established that IL-4 is effective in preventing cartilage and bone damage in mice with rheumatoid arthritis, so merging the two meant that the researchers could target the disease with a new level of precision.

Join us on our Social Networks:


Share this page with your friends on your favorite social network: